MedTrace Logo

Prevalence of Human Papillomavirus in Barrett Esophagus Compared With Controls

NCT02549053 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 219

Last updated 2015-09-15

No results posted yet for this study

Summary

The aim of this study was to determine whether the prevalence of Human PapillomaVirus (HPV) was increased in patients with Barrett esophagus compared with controls in a prospective study. Secondary objective was to identify, if present, the type of Human PapillomaVirus (HPV) associated in Barrett esophagus.

Conditions

  • Barrett Esophagus

Interventions

PROCEDURE

esophagus biopsies (pathologic and healthy zones)

Biopsies were realised in the distal third of esophagus : 4 for Barrett esophagus patients (2 in healthy zone, 2 in pathological zone).

PROCEDURE

esophagus biopsies (healthy zones)

Biopsies were realised in the distal third of esophagus :2 for control patients in healthy zone

Sponsors & Collaborators

  • University Hospital, Angers

    lead OTHER_GOV

Principal Investigators

  • François-Xavier Caroli-Bosc, PhD · UH Angers

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02549053 on ClinicalTrials.gov